首页> 外文期刊>Hepato-gastroenterology. >Radical surgery for gallbladder carcinoma: possibilities of survival.
【24h】

Radical surgery for gallbladder carcinoma: possibilities of survival.

机译:胆囊癌根治性手术:生存的可能性。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: An aggressive surgical approach in the management of gallbladder cancer (GBC) has improved survival significantly in recent years. The aim of this retrospective study is to evaluate the long-term results of surgical treatment of GBC reassessed following the TNM staging system of the AJCC-2002. METHODOLOGY: The present series considers 118 patients with GBC treated between 1982 and 2003. Seventy-four cases (63%) were females and 44 (37%) males; overall age was 63 years (range 38-91). RESULTS: Among the 118 patients with GBC, 35 (36%) underwent radical surgery: 3 pTNM IA [3 cholecystectomy (CT)], 10 IB [3CT, 3 CT + hepatic resection (HR), 4 HR], 3 IIA (3 HR), 7 IIB (3 CT+HR+ bile duct resection (BDR), 3 HR, 1 hepatopancreatoduodenectomy +CT), 10 III [4 CT+HR, 5 extensive HR (eHR), 1 HR+right colectomy+BDR+total gastrectomy], 2 IV (2 eHR). Overall 1-, 3-, 5-year survival was 67%, 46%, 34% respectively for stage IA-IB; 63%,12%, 12% for IIA-IIB; 50%, 30%, 30% for III-IV (p=ns); in particular, 1-, 3-, 5-year survival was 100%, 100%, 100% for T1a; 50%, 50%, 50% for T1b; 70%, 46%, 35% for T2; 50%, 12%, 12% for T3; 54%, 32%, 32% for T4 (p=ns); 1-, 3-, 5-year survival for patients without lymph node involvement was 58%, 44%, 37% and 60%, 15%, 15% for patients with lymph node metastases (p=ns), respectively. CONCLUSIONS: CT seems to be sufficient in T1a GBC patients but inadequate in T1b (stage IA), which requires a more aggressive approach. In stage IIB, III and IV, the presence of lymph-node metastasis is not a contraindication to aggressive surgery.
机译:背景/目的:近年来,胆囊癌(GBC)治疗中的积极外科手术方法显着提高了生存率。这项回顾性研究的目的是评估根据AJCC-2002的TNM分期系统重新评估的GBC手术治疗的长期结果。方法:本研究纳入了1982年至2003年间接受治疗的118例GBC患者。其中女性74例(63%),男性44例(37%)。总年龄为63岁(范围38-91)。结果:118例GBC患者中,有35例(36%)接受了根治性手术:3 pTNM IA [3例胆囊切除术(CT)],10 IB [3CT,3 CT +肝切除术(HR),4 HR],3 IIA( 3 HR),7 IIB(3 CT + HR +胆管切除术(BDR),3 HR,1肝胰十二指肠切除术+ CT),10 III [4 CT + HR,5广泛性HR(eHR),1 HR +右结肠切除术+ BDR +全胃切除术],2 IV(2 eHR)。 IA-IB期的1,3,5年总生存率分别为67%,46%和34%; IIA-IIB为63%,12%,12%; III-IV为50%,30%,30%(p = ns);特别是,T1a的1年,3年,5年生存率为100%,100%,100%; T1b为50%,50%,50%; T2的70%,46%,35%; T3为50%,12%,12%; T4的54%,32%,32%(p = ns);没有淋巴结转移的患者的1、3、5年生存率分别为有淋巴结转移的患者(p = ns),分别为58%,44%,37%和60%,15%,15%。结论:T1a GBC患者似乎CT足够,但T1b(IA期)不足,这需要更积极的方法。在IIB,III和IV期,淋巴结转移并不是积极手术的禁忌证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号